Safety of Daily Dose Esomeprazole for GERD for Pediatric and Adolescent Patients
Public ClinicalTrials.gov record NCT00241501. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III, Multicentre, Randomized, Double-blind, Parallel-group Study to Evaluate the Safety of Once Daily Esomeprazole for the Treatment of Clinically Diagnosed Gastroesophageal Reflux Disease (GERD) in Pediatric and Adolescent Patients 12 to 17 Years of Age, Inclusive.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is a phase III, multi-centre, randomized, double-blind study to assess the safety and tolerability of once daily treatment with esomeprazole 20 or 40 mg in pediatric and adolescent patients 12 to 17 years of age, inclusive, with clinically diagnosed GERD. The treatment period will be up to 8 weeks.
Study identification
- NCT ID
- NCT00241501
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 140 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2004 (Type not available)
- Primary completion
- Not listed
- Completion
- Apr 2005 (Actual)
- Last update posted
- Nov 19, 2010
2004 – 2005
United States locations
- U.S. sites
- 28
- U.S. states
- 20
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Phoenix | Arizona | — | — |
| Research Site | Little Rock | Arkansas | — | — |
| Research Site | Wilmington | Delaware | — | — |
| Research Site | Orlando | Florida | — | — |
| Research Site | Atlanta | Georgia | — | — |
| Research Site | Park Ridge | Illinois | — | — |
| Research Site | Indianapolis | Indiana | — | — |
| Research Site | Iowa City | Iowa | — | — |
| Research Site | Shreveport | Louisiana | — | — |
| Research Site | Boston | Massachusetts | — | — |
| Research Site | Waltham | Massachusetts | — | — |
| Research Site | Detroit | Michigan | — | — |
| Research Site | Plymouth | Minnesota | — | — |
| Research Site | Saint Paul | Minnesota | — | — |
| Research Site | Jackson | Mississippi | — | — |
| Research Site | Binghamton | New York | — | — |
| Research Site | Brooklyn | New York | — | — |
| Research Site | Buffalo | New York | — | — |
| Research Site | Johnson City | New York | — | — |
| Research Site | New Hyde Park | New York | — | — |
| Research Site | The Bronx | New York | — | — |
| Research Site | Winston-Salem | North Carolina | — | — |
| Research Site | Cleveland | Ohio | — | — |
| Research Site | Dayton | Ohio | — | — |
| Research Site | Philadelphia | Pennsylvania | — | — |
| Research Site | Chattanooga | Tennessee | — | — |
| Research Site | Burlington | Vermont | — | — |
| Research Site | Norfolk | Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00241501, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 19, 2010 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00241501 live on ClinicalTrials.gov.